Alcon Long Term Debt 2019-2022 | ALC
Alcon long term debt from 2019 to 2022. Long term debt can be defined as the sum of all long term debt fields.
- Alcon long term debt for the quarter ending December 31, 2022 was $4.541B, a 14.5% increase year-over-year.
- Alcon long term debt for 2022 was $4.541B, a 14.5% increase from 2021.
- Alcon long term debt for 2021 was $3.966B, a 0.43% increase from 2020.
- Alcon long term debt for 2020 was $3.949B, a 22.72% increase from 2019.
Alcon Annual Long Term Debt
(Millions of US $) |
| 2022 |
$4,541 |
| 2021 |
$3,966 |
| 2020 |
$3,949 |
| 2019 |
$3,218 |
| 2018 |
$ |
Alcon Quarterly Long Term Debt
(Millions of US $) |
| 2022-12-31 |
$4,541 |
| 2022-09-30 |
$3,853 |
| 2022-06-30 |
$3,883 |
| 2022-03-31 |
$3,916 |
| 2021-12-31 |
$3,966 |
| 2021-09-30 |
$3,976 |
| 2021-06-30 |
$3,986 |
| 2021-03-31 |
$3,979 |
| 2020-12-31 |
$3,949 |
| 2020-09-30 |
$3,928 |
| 2020-06-30 |
$3,909 |
| 2020-03-31 |
$3,157 |
| 2019-12-31 |
$3,218 |
| 2019-09-30 |
$3,216 |
| 2019-06-30 |
$1,751 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$32.311B |
$8.717B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
